Ameriprise’s Lam Research LRCX Stock Holding History

Ameriprise’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-65,000	Closed	-$516K	–	3822
2015 Q4	$516K	Buy	+65,000	New	+$489K	﹤0.01%	3253

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise's LRCX Position: Q2 2026 in Review

Ameriprise reduced its Lam Research (LRCX) stake by 17% in Q2 2026, selling an estimated $1.05B and leaving 17,334,906 shares worth $7.51B. The position accounts for 1.52% of the portfolio, ranked #6.

Ameriprise first reported a position in LRCX in Q2 2013 and has held it in 53 quarters since. 3,137 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

Ameriprise held 17,334,906 shares of Lam Research worth $7.51B as of Q2 2026.
Ameriprise sold 3,453,224 Lam Research shares in Q2 2026, an estimated $1.05B.
Lam Research made up 1.52% of Ameriprise's portfolio in Q2 2026, its #6 holding.
Ameriprise first reported a position in Lam Research in Q2 2013 and has held it in 53 quarters since.
3,137 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.